agilon health, inc. (NYSE:AGL) Short Interest Update

agilon health, inc. (NYSE:AGL) saw a large decrease in short interest in the month of September. As of September 30th, there was short interest totalling 36,490,000 shares, a decrease of 7.4% from the September 15th total of 39,420,000 shares. Currently, 12.1% of the company’s shares are sold short. Based on an average daily volume of 4,390,000 shares, the days-to-cover ratio is presently 8.3 days.

agilon health Stock Up 1.1 %

agilon health stock opened at $3.30 on Friday. agilon health has a 12-month low of $2.99 and a 12-month high of $19.94. The company has a market capitalization of $1.36 billion, a PE ratio of -4.71 and a beta of 0.54. The firm’s fifty day moving average is $3.92 and its 200 day moving average is $5.25. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The company’s revenue for the quarter was up 38.7% on a year-over-year basis. During the same quarter last year, the business posted ($0.04) EPS. As a group, sell-side analysts predict that agilon health will post -0.32 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Steven Sell acquired 20,000 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were bought at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Several hedge funds have recently added to or reduced their stakes in AGL. Arizona State Retirement System increased its position in shares of agilon health by 2.5% in the second quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock valued at $562,000 after acquiring an additional 2,070 shares during the period. Swiss National Bank boosted its stake in agilon health by 0.6% during the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock valued at $3,677,000 after purchasing an additional 3,400 shares during the last quarter. J.Safra Asset Management Corp increased its holdings in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after purchasing an additional 3,625 shares in the last quarter. Renaissance Capital LLC lifted its stake in agilon health by 3.0% during the 1st quarter. Renaissance Capital LLC now owns 191,122 shares of the company’s stock valued at $1,166,000 after acquiring an additional 5,551 shares during the period. Finally, CWM LLC boosted its holdings in shares of agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after acquiring an additional 7,288 shares during the last quarter.

Analyst Ratings Changes

A number of brokerages have issued reports on AGL. Deutsche Bank Aktiengesellschaft cut their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Evercore ISI cut their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Benchmark reaffirmed a “buy” rating and set a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 price target on shares of agilon health in a report on Wednesday, August 7th. Finally, Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a report on Wednesday, October 2nd. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, agilon health currently has an average rating of “Hold” and an average price target of $8.03.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.